306 related articles for article (PubMed ID: 29090526)
41. Motexafin gadolinium and involved field radiation therapy for intrinsic pontine glioma of childhood: a Children's Oncology Group phase I study.
Bradley KA; Pollack IF; Reid JM; Adamson PC; Ames MM; Vezina G; Blaney S; Ivy P; Zhou T; Krailo M; Reaman G; Mehta MP;
Neuro Oncol; 2008 Oct; 10(5):752-8. PubMed ID: 18715950
[TBL] [Abstract][Full Text] [Related]
42. Prolonged survival after treatment of diffuse intrinsic pontine glioma with radiation, temozolamide, and bevacizumab: report of 2 cases.
Aguilera DG; Mazewski C; Hayes L; Jordan C; Esiashivilli N; Janns A; Macdonald TJ
J Pediatr Hematol Oncol; 2013 Jan; 35(1):e42-6. PubMed ID: 23249962
[TBL] [Abstract][Full Text] [Related]
43. Apparent diffusion coefficient histogram metrics correlate with survival in diffuse intrinsic pontine glioma: a report from the Pediatric Brain Tumor Consortium.
Poussaint TY; Vajapeyam S; Ricci KI; Panigrahy A; Kocak M; Kun LE; Boyett JM; Pollack IF; Fouladi M
Neuro Oncol; 2016 May; 18(5):725-34. PubMed ID: 26487690
[TBL] [Abstract][Full Text] [Related]
44. Convection-enhanced delivery for diffuse intrinsic pontine glioma: a single-centre, dose-escalation, phase 1 trial.
Souweidane MM; Kramer K; Pandit-Taskar N; Zhou Z; Haque S; Zanzonico P; Carrasquillo JA; Lyashchenko SK; Thakur SB; Donzelli M; Turner RS; Lewis JS; Cheung NV; Larson SM; Dunkel IJ
Lancet Oncol; 2018 Aug; 19(8):1040-1050. PubMed ID: 29914796
[TBL] [Abstract][Full Text] [Related]
45. Phase 1 trial, pharmacokinetics, and pharmacodynamics of dasatinib combined with crizotinib in children with recurrent or progressive high-grade and diffuse intrinsic pontine glioma.
Broniscer A; Jia S; Mandrell B; Hamideh D; Huang J; Onar-Thomas A; Gajjar A; Raimondi SC; Tatevossian RG; Stewart CF
Pediatr Blood Cancer; 2018 Jul; 65(7):e27035. PubMed ID: 29512900
[TBL] [Abstract][Full Text] [Related]
46. Survival benefit for patients with diffuse intrinsic pontine glioma (DIPG) undergoing re-irradiation at first progression: A matched-cohort analysis on behalf of the SIOP-E-HGG/DIPG working group.
Janssens GO; Gandola L; Bolle S; Mandeville H; Ramos-Albiac M; van Beek K; Benghiat H; Hoeben B; Morales La Madrid A; Kortmann RD; Hargrave D; Menten J; Pecori E; Biassoni V; von Bueren AO; van Vuurden DG; Massimino M; Sturm D; Peters M; Kramm CM
Eur J Cancer; 2017 Mar; 73():38-47. PubMed ID: 28161497
[TBL] [Abstract][Full Text] [Related]
47. Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma.
Gállego Pérez-Larraya J; Garcia-Moure M; Labiano S; Patiño-García A; Dobbs J; Gonzalez-Huarriz M; Zalacain M; Marrodan L; Martinez-Velez N; Puigdelloses M; Laspidea V; Astigarraga I; Lopez-Ibor B; Cruz O; Oscoz Lizarbe M; Hervas-Stubbs S; Alkorta-Aranburu G; Tamayo I; Tavira B; Hernandez-Alcoceba R; Jones C; Dharmadhikari G; Ruiz-Moreno C; Stunnenberg H; Hulleman E; van der Lugt J; Idoate MÁ; Diez-Valle R; Esparragosa Vázquez I; Villalba M; de Andrea C; Núñez-Córdoba JM; Ewald B; Robbins J; Fueyo J; Gomez-Manzano C; Lang FF; Tejada S; Alonso MM
N Engl J Med; 2022 Jun; 386(26):2471-2481. PubMed ID: 35767439
[TBL] [Abstract][Full Text] [Related]
48. Nimotuzumab-containing regimen for pediatric diffuse intrinsic pontine gliomas: a retrospective multicenter study and review of the literature.
Kebudi R; Cakir FB; Bay SB; Gorgun O; Altınok P; Iribas A; Agaoglu FY; Darendeliler E
Childs Nerv Syst; 2019 Jan; 35(1):83-89. PubMed ID: 30417211
[TBL] [Abstract][Full Text] [Related]
49. Malignant brainstem tumors in children, excluding diffuse intrinsic pontine gliomas.
Klimo P; Nesvick CL; Broniscer A; Orr BA; Choudhri AF
J Neurosurg Pediatr; 2016 Jan; 17(1):57-65. PubMed ID: 26474099
[TBL] [Abstract][Full Text] [Related]
50. Proton therapy for newly diagnosed pediatric diffuse intrinsic pontine glioma.
Muroi A; Mizumoto M; Ishikawa E; Ihara S; Fukushima H; Tsurubuchi T; Sakurai H; Matsumura A
Childs Nerv Syst; 2020 Mar; 36(3):507-512. PubMed ID: 31728705
[TBL] [Abstract][Full Text] [Related]
51. Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: a Children's Oncology Group phase II study.
Korones DN; Fisher PG; Kretschmar C; Zhou T; Chen Z; Kepner J; Freeman C
Pediatr Blood Cancer; 2008 Feb; 50(2):227-30. PubMed ID: 17278121
[TBL] [Abstract][Full Text] [Related]
52. Correlation of multimodal
Morana G; Tortora D; Bottoni G; Puntoni M; Piatelli G; Garibotto F; Barra S; Giannelli F; Cistaro A; Severino M; Verrico A; Milanaccio C; Massimino M; Garrè ML; Rossi A; Piccardo A
Theranostics; 2020; 10(26):11881-11891. PubMed ID: 33204317
[TBL] [Abstract][Full Text] [Related]
53. Palliative and end-of-life care for children with diffuse intrinsic pontine glioma: results from a London cohort study and international survey.
Veldhuijzen van Zanten SE; van Meerwijk CL; Jansen MH; Twisk JW; Anderson AK; Coombes L; Breen M; Hargrave OJ; Hemsley J; Craig F; Cruz O; Kaspers GJ; van Vuurden DG; Hargrave DR;
Neuro Oncol; 2016 Apr; 18(4):582-8. PubMed ID: 26459800
[TBL] [Abstract][Full Text] [Related]
54. [Formula: see text] The neuropsychological profile of children with Diffuse Intrinsic Pontine Glioma (DIPG) before and after radiation therapy: A prospective longitudinal study.
Rhodes A; Martin S; Toledo-Tamula MA; Loucas C; Glod J; Warren KE; Wolters PL
Child Neuropsychol; 2023 Aug; 29(6):934-958. PubMed ID: 36369715
[TBL] [Abstract][Full Text] [Related]
55. Incidental diagnosis of diffuse intrinsic pontine glioma in children.
Wright KD; Sabin ND; Cheuk D; McNall-Knapp R; Shurtleff SA; Gajjar A; Broniscer A
Pediatr Blood Cancer; 2015 Jun; 62(6):1081-3. PubMed ID: 25598012
[TBL] [Abstract][Full Text] [Related]
56. Hypofractionated radiotherapy in children with diffuse intrinsic pontine glioma.
Hayashi A; Ito E; Omura M; Aida N; Tanaka M; Tanaka Y; Sato H; Miyagawa N; Yokosuka T; Iwasaki F; Hamanoue S; Goto H
Pediatr Int; 2020 Jan; 62(1):47-51. PubMed ID: 31785177
[TBL] [Abstract][Full Text] [Related]
57. Treatment of children with diffuse intrinsic pontine gliomas with chemoradiotherapy followed by a combination of temozolomide, irinotecan, and bevacizumab.
Zaky W; Wellner M; Brown RJ; Blüml S; Finlay JL; Dhall G
Pediatr Hematol Oncol; 2013 Oct; 30(7):623-32. PubMed ID: 24050762
[TBL] [Abstract][Full Text] [Related]
58. A phase II study of gefitinib and irradiation in children with newly diagnosed brainstem gliomas: a report from the Pediatric Brain Tumor Consortium.
Pollack IF; Stewart CF; Kocak M; Poussaint TY; Broniscer A; Banerjee A; Douglas JG; Kun LE; Boyett JM; Geyer JR
Neuro Oncol; 2011 Mar; 13(3):290-7. PubMed ID: 21292687
[TBL] [Abstract][Full Text] [Related]
59. Diffuse intrinsic pontine glioma cells are vulnerable to low intensity electric fields delivered by intratumoral modulation therapy.
Deweyert A; Iredale E; Xu H; Wong E; Schmid S; Hebb MO
J Neurooncol; 2019 May; 143(1):49-56. PubMed ID: 30852713
[TBL] [Abstract][Full Text] [Related]
60. Brain stem tumors in children and adolescents: single institutional experience.
Garzón M; García-Fructuoso G; Guillén A; Suñol M; Mora J; Cruz O
Childs Nerv Syst; 2013 Aug; 29(8):1321-31. PubMed ID: 23666431
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
